I agree with you , not sure if they want to submit
Post# of 145247
You slide look good , unfortunately , all of this will not happen in Q1 .2019....
but hopefully in Q3 , and being that they gave them now rolling review , time of approval might not be to much different ..
I really think FDA see the positives in Leronlimab and is working with them...
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)